Skip to main content
HairCited

Medical treatment of noncicatricial alopecia.

Maria K Hordinsky
Review Seminars in cutaneous medicine and surgery 2006 23 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D16616303'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
narrative review
Intervention
Medical treatment of noncicatricial alopecia. varies by treatment
Vergleichsgruppe
Placebo
Wirkungsrichtung
Positive
Verzerrungsrisiko
Unclear

Abstract

Androgenetic alopecia, alopecia areata, and telogen effluvium are the primary nonscarring alopecias found in clinical practice. Androgenetic alopecia is considered to be the most common form of human alopecia and is postulated to affect more than 50% of men by age 50. Alopecia areata affects up to 2% of the U.S. population. Telogen effluvium frequently occurs after major life events, such as a severe illness, childbirth, or high fever, and may be associated with the use of certain medications or iron deficiency, particularly in women. The focus of this review is on the medical treatment of these common hair loss conditions.

Used In Evidence Reviews

Similar Papers